On Tuesday, Kura Oncology Inc (NASDAQ: KURA) was -4.48% drop from the session before settling in for the closing price of $8.25. A 52-week range for KURA has been $6.98 – $24.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -17.81%. With a float of $72.37 million, this company’s outstanding shares have now reached $77.75 million.
Let’s determine the extent of company efficiency that accounts for 142 employees. In terms of profitability, gross margin is 48.82%, operating margin of -17126.14%, and the pretax margin is -15555.28%.
Kura Oncology Inc (KURA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Kura Oncology Inc stocks. The insider ownership of Kura Oncology Inc is 6.94%, while institutional ownership is 99.81%. The most recent insider transaction that took place on Jan 28 ’25, was worth 38,958. In this transaction SVP, Finance & Accounting of this company sold 4,949 shares at a rate of $7.87, taking the stock ownership to the 88,193 shares. Before that another transaction happened on Jan 28 ’25, when Company’s Chief Medical Officer sold 4,963 for $7.87, making the entire transaction worth $39,068. This insider now owns 88,253 shares in total.
Kura Oncology Inc (KURA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -17.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.42% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
You can see what Kura Oncology Inc (KURA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Looking closely at Kura Oncology Inc (NASDAQ: KURA), its last 5-days average volume was 0.92 million, which is a drop from its year-to-date volume of 1.67 million. As of the previous 9 days, the stock’s Stochastic %D was 21.36%. Additionally, its Average True Range was 0.47.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 6.95%, which indicates a significant decrease from 20.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.18% in the past 14 days, which was lower than the 84.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.43, while its 200-day Moving Average is $16.42. However, in the short run, Kura Oncology Inc’s stock first resistance to watch stands at $8.11. Second resistance stands at $8.34. The third major resistance level sits at $8.47. If the price goes on to break the first support level at $7.75, it is likely to go to the next support level at $7.62. Should the price break the second support level, the third support level stands at $7.39.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
There are 77,764K outstanding shares of the company, which has a market capitalization of 612.78 million. As of now, sales total 0 K while income totals -152,630 K. Its latest quarter income was 0 K while its last quarter net income were -54,400 K.
